These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30891618)

  • 61. Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria.
    Rahmel T; Schäfer ST; Frey UH; Adamzik M; Peters J
    PLoS One; 2018; 13(5):e0197637. PubMed ID: 29782519
    [TBL] [Abstract][Full Text] [Related]  

  • 62. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
    Scheffer AR; Holdenrieder S; Kristiansen G; von Ruecker A; Müller SC; Ellinger J
    World J Urol; 2014 Apr; 32(2):353-8. PubMed ID: 23266581
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer.
    Wang Q; Zhang H; Shen X; Ju S
    Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating miR-448 acts as a potential diagnostic biomarker for multiple myeloma.
    Chen D; Chen T; Wang L; Zhang Z; Xing E
    Hematology; 2022 Dec; 27(1):847-852. PubMed ID: 35938956
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.
    Tsukamoto S; Løvendorf MB; Park J; Salem KZ; Reagan MR; Manier S; Zavidij O; Rahmat M; Huynh D; Takagi S; Kawano Y; Kokubun K; Thrue CA; Nagano K; Petri A; Roccaro AM; Capelletti M; Baron R; Kauppinen S; Ghobrial IM
    Leukemia; 2018 Aug; 32(8):1739-1750. PubMed ID: 29925904
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.
    Gao YC; Wu J
    Tumour Biol; 2015 Jun; 36(6):4843-50. PubMed ID: 25636451
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients.
    Bao Y; Wei M; Ji X
    J Clin Lab Anal; 2020 May; 34(5):e23168. PubMed ID: 31908003
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma.
    Huang JJ; Yu J; Li JY; Liu YT; Zhong RQ
    Med Oncol; 2012 Dec; 29(4):2402-8. PubMed ID: 22447484
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients.
    Perez-Sanchez C; Font-Ugalde P; Ruiz-Limon P; Lopez-Pedrera C; Castro-Villegas MC; Abalos-Aguilera MC; Barbarroja N; Arias-de la Rosa I; Lopez-Montilla MD; Escudero-Contreras A; Lopez-Medina C; Collantes-Estevez E; Jimenez-Gomez Y
    Hum Mol Genet; 2018 Mar; 27(5):875-890. PubMed ID: 29329380
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
    Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
    BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
    Ng L; Wan TM; Man JH; Chow AK; Iyer D; Chen G; Yau TC; Lo OS; Foo DC; Poon JT; Leung WK; Pang RW; Law WL
    Oncotarget; 2017 Apr; 8(16):27393-27400. PubMed ID: 28404964
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Machine Learning Analysis of MicroRNA Expression Data Reveals Novel Diagnostic Biomarker for Ischemic Stroke.
    Zhao X; Chen X; Wu X; Zhu L; Long J; Su L; Gu L
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105825. PubMed ID: 34022583
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.
    Musolino C; Oteri G; Allegra A; Mania M; D'Ascola A; Avenoso A; Innao V; Allegra AG; Campo S
    Ann Hematol; 2018 Jul; 97(7):1259-1269. PubMed ID: 29546453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Changes in circulating microRNA-126 levels are associated with immune imbalance in children with acute asthma.
    Tian M; Ji Y; Wang T; Zhang W; Zhou Y; Cui Y
    Int J Immunopathol Pharmacol; 2018; 32():2058738418779243. PubMed ID: 29809062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.